Erythrina droogmansiana
Erythrina droogmansiana · Accepted scientific name
Scientific literature: Very Sparse (1 studies) · ★☆☆☆☆
Erythrina droogmansiana is a distinctive botanical species known for its unique medicinal potential and biological properties. Researchers have identified specific bioactive compounds within the plant, most notably Abyssinone V 4'-methyl ether. This particular chemical serves as a significant focus for studies investigating the plant's complex chemical profile. Beyond its traditional uses, current scientific interest highlights its promising antitumor activities. Consequently, this species represents an important subject in the ongoing search for novel therapeutic agents.
- Synonyms
- Erythrina Hylobia
- Common names
- Not available
- Family
- Fabaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Synonyms
Erythrina droogmansiana is a distinctive species often recognized for its striking appearance and botanical significance. In many scientific records, this plant is also identified by its synonym, Erythrina hylobia. This nomenclatural overlap can sometimes cause confusion for researchers and gardeners alike. However, understanding these synonymous relationships is essential for accurate botanical classification and study. Recognizing both names ensures that the plant is correctly cataloged within diverse global databases.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Erythrina droogmansiana is a fascinating species that belongs to the vast kingdom Plantae. Within this kingdom, it is specifically categorized under the class Equisetopsida. The plant is further organized into the order Fabales, reflecting its evolutionary lineage. It holds a distinguished place within the family Fabaceae, which is known for its diverse group of flowering plants. Finally, this species is identified as a member of the genus Erythrina, distinguishing it from other botanical relatives.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Fabales |
| Family | Fabaceae |
| Genus | Erythrina |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Erythrina droogmansiana is a notable species with a broad distribution spanning several key regions across the African continent. In East Tropical Africa, it can be found thriving within the landscapes of Uganda. Its presence extends into South Tropical Africa, specifically documented in the country of Angola. The plant also populates parts of West-Central Tropical Africa, including Cameroon and the Central African Republic. Furthermore, its natural range reaches into the Democratic Republic of the Congo, highlighting its widespread ecological footprint.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Erythrina droogmansiana is a self-supporting tree characterized by its sturdy and upright growth form. This species can reach a substantial maximum height of 25 meters in the wild. Its impressive stature makes it a prominent feature in its natural landscape.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Erythrina droogmansiana has emerged as a significant subject of interest due to its potential therapeutic applications in cancer treatment. Research focusing on this plant has identified Abyssinone V-4' methyl ether (AVME) as a key compound with notable antiproliferative effects. Studies conducted on various cancer cell lines, including MCF-7 and HepG2, demonstrate that AVME effectively inhibits cell growth. Furthermore, in vivo testing on mice suggests that the compound provides a protective effect against mammary gland hyperplasia and reduces tumor volume. These findings strongly indicate that Erythrina droogmansiana possesses valuable antitumor properties that warrant further scientific exploration.
Compounds
Erythrina droogmansiana serves as a significant botanical source for the isolation of the bioactive compound Abyssinone V 4'-methyl ether. Recent scientific investigations have focused on this specific metabolite due to its profound antiproliferative effects against various cancer cell lines, including MCF-7 and HepG2. In vivo studies conducted on Swiss mice demonstrate that the compound can effectively inhibit mammary gland hyperplasia induced by chemical carcinogens. By reducing tumor incidence, weight, and volume, Abyssinone V 4'-methyl ether shows remarkable potential in protecting against breast tissue abnormalities. Consequently, this plant-derived substance represents a promising candidate for the future development of novel cancer therapeutics.
Conditions
Erythrina droogmansiana contains Abyssinone V-4' methyl ether, a compound that effectively treats 7,12-dimethylbenz(a)anthracene (DMBA-) induced breast tumors in mice. This plant derivative also acts to inhibit general cell growth through its antiproliferative properties. Furthermore, it treats DMBA-induced mammary glands hyperplasia by reducing tumor incidence, weight, and volume. The extract demonstrates specific medicinal efficacy by treating the DU145 cancer cell line. Finally, it shows significant antitumor activity in the treatment of HepG2 cells.